| Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition A Augert, E Eastwood, AH Ibrahim, N Wu, E Grunblatt, R Basom, D Liggitt, ... Science signaling 12 (567), eaau2922, 2019 | 179 | 2019 |
| Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition D Jia, A Augert, DW Kim, E Eastwood, N Wu, AH Ibrahim, KB Kim, ... Cancer discovery 8 (11), 1422-1437, 2018 | 145 | 2018 |
| NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer N Wu, D Jia, AH Ibrahim, CJ Bachurski, RM Gronostajski, D MacPherson Oncotarget 7 (36), 57514, 2016 | 72 | 2016 |
| MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity E Grunblatt, N Wu, H Zhang, X Liu, JP Norton, Y Ohol, P Leger, JB Hiatt, ... Genes & Development 34 (17-18), 1210-1226, 2020 | 65 | 2020 |
| MAX functions as a tumor suppressor and rewires metabolism in small cell lung cancer A Augert, H Mathsyaraja, AH Ibrahim, B Freie, MJ Geuenich, PF Cheng, ... Cancer cell 38 (1), 97-114. e7, 2020 | 57 | 2020 |
| Crebbp loss drives small cell lung cancer and increases sensitivity to HDAC inhibition. Cancer Discov. 2018; 8: 1422–1437. doi: 10.1158/2159-8290 D Jia, A Augert, DW Kim, E Eastwood, N Wu, AH Ibrahim, KB Kim, ... CD-18-0385.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 15 | |
| Crebbp loss drives small cell lung cancer and increases sensitivity to HDAC inhibition. Cancer Discov. 2018; 8: 1422–37 D Jia, A Augert, DW Kim, E Eastwood, N Wu, AH Ibrahim, KB Kim, ... | 5 | |
| Activity of HER2-and TROP2-antibody drug conjugates (ADCs) in small cell lung cancer (SCLC) models with SLFN11 as a predictive biomarker B Zhang, A Ibrahim, CA Stewart, L Diao, Q Wang, L Shen, Y xi, A Serrano, ... Cancer Research 84 (6_Supplement), 6392-6392, 2024 | | 2024 |
| Advancing personalized therapies for small cell lung cancer: Exploring HER2-targeting antibody-drug conjugates (ADCs) and SLFN11 biomarker insights AH Ibrahim, B Zhang, CA Stewart, A Serrano, LM Solis, WL Wang, ... MOLECULAR CANCER THERAPEUTICS 22 (12), 2023 | | 2023 |
| Abstract LB_A22: Advancing personalized therapies for small cell lung cancer: Exploring HER2-targeting antibody-drug conjugates (ADCs) and SLFN11 biomarker insights AH Ibrahim, B Zhang, CA Stewart, A Serrano, LM Solis, WL Wang, ... Molecular Cancer Therapeutics 22 (12_Supplement), LB_A22-LB_A22, 2023 | | 2023 |
| Abstract B08: Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition A Augert, E Eastwood, AH Ibrahim, N Wu, E Grunblatt, R Basom, ... Clinical Cancer Research 24 (17_Supplement), B08-B08, 2018 | | 2018 |
| WiOpt 2009 W Wang, L Ong, M Motani, R El Haddad, B Smith, S Vishwanath, V Simon, ... | | |
David MacPhersonFred Hutchinson Cancer Research Center在 fhcrc.org 的电子邮件经过验证
